NRXN1 and breast cancer: Breast cancer patients with lymph node involvement had 15.70-fold higher NRXN-1 mRNA expression while breast cancer patients without any lymph nodes involvement had 8.40-fold NRXN-1 mRNA expression (p < 0.0001).